GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now becoming a prominent focus in healthcare studies, largely due to its remarkable impact on managing diseases such as second type diabetes and weight gain. New studies have shown that beyond glucose regulation, GLP-1 agonists offer